Effect of new trial drug on clinical and paraclinical symptoms in COVID-19

Phase 3

Recruiting

Conditions: COVID-19.
COVID-19, virus identified
U07.1

Registration Number: IRCT20200509047373N2

Lead Sponsor: Health Medicine Chemistry Company

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 120

Inclusion Criteria

Having definite COVID-19 disease and get hospitalized
Both sexes
Age over 15 years
Obtaining informed consent to participate in the trial
Non-participation in another clinical trial simultaneously
Patients admitted to IC

Exclusion Criteria

Diagnosis of the disease just based on physician diagnosis
Pregnancy (according to the patient's statement and examination by a physician)
Breastfeeding (according to the patient's statement)

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Respiratory Rate. Timepoint: Daily. Method of measurement: Observation.;Oxygen saturation (SpO2). Timepoint: Daily. Method of measurement: Pulse Oximeter.;Serum White Blood Cell count. Timepoint: Before intervention and 14 days after intervention. Method of measurement: Laboratory cell counter.;Serum CRP level. Timepoint: Before intervention and 14 days after intervention. Method of measurement: Biochemical method.;ESR (Erythrocyte Sedimentation Rate). Timepoint: Before intervention and 14 days after intervention. Method of measurement: Checking the sedimentation rate of erythrocytes in a special tube within one hour.;Number of hospitalization days. Timepoint: After intervention. Method of measurement: Questionnaire.;Mortality. Timepoint: Daily. Method of measurement: Questionnaire.

Secondary Outcome Measures

Name	Time	Method
The end time of dry Cough. Timepoint: Daily. Method of measurement: ?Daily symptom recording questionnaire.;The time of recovery from difficulty in breathing or shortness of breath. Timepoint: Daily. Method of measurement: Daily symptom recording questionnaire.;The time of recovery of temperature equal to or grater than 37.8 C. Timepoint: Daily. Method of measurement: Daily symptom recording questionnaire.